Goodwill And Related Intangible Assets

5. GOODWILL AND RELATED INTANGIBLE ASSETS

Goodwill

The changes in the carrying amount of goodwill for the three months ended March 31, 2012 are as follows (in thousands):


Balance as of December 31, 2011	$	348,326
Acquired goodwill		50
Foreign currency translation		760
Balance as of March 31, 2012	$	349,136

The goodwill balances as of March 31, 2012 and December 31, 2011 are net of accumulated impairment losses of $125,597,000.

Acquired Intangible Assets

Acquired intangible assets consist of the following (in thousands):


		March 31, 2012				December 31, 2011
		Gross				Gross
		Carrying	Accumulated			Carrying		Accumulated
		Amount	Amortization			Amount		Amortization	Estimated Life
Indefinite-lived intangible assets:
Trademarks	$	46,930	$	–	$	46,760		$ –	Indefinite
Finite-lived intangible assets:
Trademarks		1,970		941		1,968		921	2 to 15 Years
Unpatented technology		22,117		3,974		22,117		3,577	5 to 20 Years
Customer relationships		48,820		21,619		48,276		20,512	5 to 16 Years
Non-compete agreements		2,857		2,386		2,857		2,303	5 to 10 Years
Backlog		1,200		800		1,200		600	1 to 2 Years
		76,964		29,720		76,418		27,913
Total acquired intangible assets	$	123,894	$	29,720	$	123,178	$	27,913

The Company incurred $1,631,000 and $1,148,000 of acquired intangible asset amortization expense for the three months ended March 31, 2012 and 2011, respectively.

Amortization expense related to acquired intangible assets for the remainder of fiscal 2012 and the next five years thereafter is estimated as follows (in thousands):


2012	$	4,879
2013	$	5,716
2014	$	4,828
2015	$	4,692
2016	$	4,357
2017	$	3,988

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details